The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.
The AKR inbred mouse strain displays a high incidence of spontaneous T cell lymphomas that arise predominantly in the thymus of 6 to 12-month-old mice. Heterogenous nonacute transforming retroviruses are associated with the etiology of the disease: the endogenous ecotropic viruses (inherited in AKR mice at two non-linked chromosomal loci, Akv-1 and Akv-2), the xenotropic virus and recombinant viruses. Prevention of spontaneous T cell lymphomagenesis in AKR mice by passive anti-viral immunotherapy was accomplished by suppressing endogenous ecotropic virus release. Treatment with monoclonal antibody Hy-72 reacting only with Akv1 type ecotropic viruses, or with mAb 18-5 with specificity for both ecotropic and MCF recombinant virus envelope glycoprotein (administered from birth for 10 days) inhibited similarly T cell lymphoma development. A reduced thymus cellularity observed in these mAb treated mice coincided with reduced level of earliest intrathymic low CD4 precursor population in their thymus. The role of endogenous viruses (MuLV) and presence of potential lymphoma cells (PLCs) (identified among bone marrow cells of untreated AKR mice) in enhanced T cell lymphomagenesis in AKR mice, triggered by different leukemogenic agents, was evaluated. Intrathymic injection of the radiation leukemia virus variant A-RadLV or administration of methylnitrosourea resulted in a high lymphoma incidence within a short latent period of 80-100 days irrespective of the presence or absence of MuLV or PLCs in these treated mice. Thus, a direct action of these agents on thymocytes seems to occur. The high susceptibility of untreated AKR mice to radiation induced T cell lymphomagenesis was not affected by pretreatment with mAb Hy-72; in contrast to markedly reduced sensitivity following pretreatment with mAb 18-5 (15 vs 100%). The mAb 18-5 induced resistance to radiation lymphomagenesis seems to be related to defects in the bone marrow stem cell pool as well as in the thymus microenvironment of mAb 18-5 treated mice. Thus, different developmental pathways are involved in enhanced T cell lymphomagenesis in AKR mice.
Haran-Ghera
N
N
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Peled
A
A
Wu
L
L
Shortman
K
K
Brightman
B K
BK
Fan
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D004198:Disease Susceptibility; D016219:Immunotherapy, Adoptive; D018655:Lymphocyte Count; D016399:Lymphoma, T-Cell / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D008770:Methylnitrosourea; D051379:Mice; D008806:Mice, Inbred AKR; D016721:Radiation Leukemia Virus; D012190:Retroviridae / Q000276:immunology; D012192:Retroviridae Infections / Q000473:pathology / Q000517:prevention & control / Q000821:virology; D013154:Spleen / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology; D014412:Tumor Virus Infections / Q000473:pathology / Q000517:prevention & control / Q000821:virology
D000911:Antibodies, Monoclonal; D008770:Methylnitrosourea